Skip to main content
. 2022 Feb 26;14:17588359221079125. doi: 10.1177/17588359221079125

Figure 3.

Figure 3.

Genetic landscape of baseline and progression status from enrolled 36 EGFR mutant lung cancer patients. (a) Oncoplot of somatic SNVs comparison at baseline and at the time of progression in EGFR mutant lung cancer patients. (b) Comparison of oncoplots showing copy number variations at baseline and at the time of progression.